Gilead Sciences, Inc. (GILD)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2025-12-30

Key Insights

  • Daniel P. O'Day, the Chairman and CEO of Gilead Sciences, sold 10,000 shares of common stock on December 29, 2025 pursuant to a pre-established 10b5-1 trading plan.
  • The sale price range was $124.40 to $125.16 per share, and O'Day still holds 566,698 shares of Gilead stock directly.
  • Insider selling can sometimes indicate management's view on the company's near-term prospects, though a 10b5-1 plan limits the interpretation of this transaction.
Filing tone (AI): Neutral
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new Gilead Sciences, Inc. filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.